EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Date

Title

File

Times

2023-03-17

NEXT DAY DISCLOSURE RETURN

897

2023-03-16

NEXT DAY DISCLOSURE RETURN

920

2023-03-15

NEXT DAY DISCLOSURE RETURN

924

2023-03-14

NEXT DAY DISCLOSURE RETURN

895

2023-03-13

NEXT DAY DISCLOSURE RETURN

863

2023-03-08

FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022

868

2023-03-08

ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022

909

2023-03-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2023

862

2023-02-24

NOTICE OF BOARD MEETING

890

2023-02-22

UPDATE ON DISCLOSEABLE TRANSACTION AMENDMENT AGREEMENT TO THE CO-DEVELOPMENT LICENSE AGREEMENT WITH SHANGHAI HENLIUS BIOTECH, INC. FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION

876

2023-02-10

VOLUNTARY ANNOUNCEMENT FIRST PATIENT FIRST DOSE COMPLETED IN THE UNITED STATES IN AN INTERNATIONAL MULTI-CENTRE PHASE 3 CLINICAL STUDY IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS FOR THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

943

2023-02-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2023

904

2023-01-10

1002

2023-01-04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2022

936

2022-12-29

NEXT DAY DISCLOSURE RETURN

995

2022-12-21

NEXT DAY DISCLOSURE RETURN

960

2022-12-02

NEXT DAY DISCLOSURE RETURN

1001

2022-12-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2022

927

2022-12-01

NEXT DAY DISCLOSURE RETURN

945

2022-11-30

NEXT DAY DISCLOSURE RETURN

971

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT